There are more than 250,000 influenza-related deaths each year. Of special concern are the influenza H1N1 and H5N1 strains, which harbor H1 and H5 hemagglutinin (HA) and present potential for future pandemic outbreaks. Current treatments include Tamiflu (oseltamivir) and Relenza (zanamivir), which target the membrane protein neuraminidase (NA). Unfortunately, resistance is increasing in circulating influenza strains. For example, the 2008-2009 H1N1 strain exhibited ~100% resistance against Tamiflu, and thus influenza may be considered as a drug-resistant pathogen. As a consequence, new targets in influenza are urgently needed. HA plays a critical role in influenza entry and thus it i an attractive and novel target for therapeutic intervention. In the first step of influenza entry, A binds to the cellular receptor, sialic acid. Subsequently, the virus enters the cell via receptor-mediated endocytosis. In the endosome, the resulting low pH triggers a large conformational change in HA, which subsequently causes the viral membrane to fuse with the endosomal membrane to allow escape from the endosome. Entry inhibitors could conceivably target either the receptor binding step (binding inhibitors) or the membrane fusion step (fusion inhibitors). In this project we will develop NMR-based screening methods of small molecule libraries to influenza H1 and H5 HA with the long-term goal of developing binding and fusion inhibitors.
The Specific Aims are: (1) discovery of chemical probes that bind to influenza H1 and H5 HA in the neutral pH conformation;(2) discovery of chemical probes that bind to influenza H1 and H5 HA in the low pH conformation;(3) identify the site of probe binding by NMR competition experiments. Importantly, the NMR methods could be exploited to identify and improve small molecule therapeutics, characterize probe-envelope interactions in whole virus, and be applied to other viruses such as Ebola, HIV and SARS-CoV.
Hemagglutinin plays a critical role in the entry of influenza. This application is designed to develop NMR techniques to give new insights into hemagglutinin structure and function, which may be exploited for the development of novel drug therapies.
| Basu, Arnab; Komazin-Meredith, Gloria; McCarthy, Courtney et al. (2017) Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546. ACS Infect Dis 3:330-335 |
| Antanasijevic, Aleksandar; Hafeman, Nicholas J; Tundup, Smanla et al. (2016) Stabilization and Improvement of a Promising Influenza Antiviral: Making a PAIN PAINless. ACS Infect Dis 2:608-615 |
| Antanasijevic, Aleksandar; Kingsley, Carolyn; Basu, Arnab et al. (2016) Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions. J Biomol NMR 64:255-65 |
| Nomme, Julian; Antanasijevic, Aleksandar; Caffrey, Michael et al. (2015) Structural Basis of a Key Factor Regulating the Affinity between the Zonula Occludens First PDZ Domain and Claudins. J Biol Chem 290:16595-606 |
| Antanasijevic, Aleksandar; Basu, Arnab; Bowlin, Terry L et al. (2014) Mutagenesis studies of the H5 influenza hemagglutinin stem loop region. J Biol Chem 289:22237-45 |
| Antanasijevic, Aleksandar; Ramirez, Benjamin; Caffrey, Michael (2014) Comparison of the sensitivities of WaterLOGSY and saturation transfer difference NMR experiments. J Biomol NMR 60:37-44 |
| Basu, Arnab; Antanasijevic, Aleksandar; Wang, Minxiu et al. (2014) New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol 88:1447-60 |
| McCullough, Christopher; Wang, Minxiu; Rong, Lijun et al. (2012) Characterization of influenza hemagglutinin interactions with receptor by NMR. PLoS One 7:e33958 |
